Fairlie DP - Search Results

1

Antiproliferative and phenotype-transforming antitumor agents derived from cysteine.

Glenn MP, Kahnberg P, Boyle GM, Hansford KA, Hans D, Martyn AC, Parsons PG, Fairlie DP. Glenn MP, et al. Among authors: fairlie dp. J Med Chem. 2004 Jun 3;47(12):2984-94. doi: 10.1021/jm030222i. J Med Chem. 2004. PMID: 15163181

2

Biphasic response of the metallothionein promoter to ultraviolet radiation in human melanoma cells.

Hansen C, Ablett E, Green A, Sturm RA, Dunn IS, Fairlie DP, West ML, Parsons PG. Hansen C, et al. Among authors: fairlie dp. Photochem Photobiol. 1997 Mar;65(3):550-5. doi: 10.1111/j.1751-1097.1997.tb08603.x. Photochem Photobiol. 1997. PMID: 9077140

3

Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells.

Parsons PG, Hansen C, Fairlie DP, West ML, Danoy PA, Sturm RA, Dunn IS, Pedley J, Ablett EM. Parsons PG, et al. Among authors: fairlie dp. Biochem Pharmacol. 1997 Jun 1;53(11):1719-24. doi: 10.1016/s0006-2952(97)00016-6. Biochem Pharmacol. 1997. PMID: 9264325

4

Towards protein surface mimetics.

Fairlie DP, West ML, Wong AK. Fairlie DP, et al. Curr Med Chem. 1998 Feb;5(1):29-62. Curr Med Chem. 1998. PMID: 9481033 Review.

5

Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.

Wong AK, Finch AM, Pierens GK, Craik DJ, Taylor SM, Fairlie DP. Wong AK, et al. Among authors: fairlie dp. J Med Chem. 1998 Aug 27;41(18):3417-25. doi: 10.1021/jm9800651. J Med Chem. 1998. PMID: 9719594

6

Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a.

Finch AM, Wong AK, Paczkowski NJ, Wadi SK, Craik DJ, Fairlie DP, Taylor SM. Finch AM, et al. Among authors: fairlie dp. J Med Chem. 1999 Jun 3;42(11):1965-74. doi: 10.1021/jm9806594. J Med Chem. 1999. PMID: 10354404

7

Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate.

Qiu L, Kelso MJ, Hansen C, West ML, Fairlie DP, Parsons PG. Qiu L, et al. Among authors: fairlie dp. Br J Cancer. 1999 Jun;80(8):1252-8. doi: 10.1038/sj.bjc.6690493. Br J Cancer. 1999. PMID: 10376979 Free PMC article.

8

Protease inhibitors: current status and future prospects.

Leung D, Abbenante G, Fairlie DP. Leung D, et al. Among authors: fairlie dp. J Med Chem. 2000 Feb 10;43(3):305-41. doi: 10.1021/jm990412m. J Med Chem. 2000. PMID: 10669559 Review. No abstract available.

9

Conformational selection of inhibitors and substrates by proteolytic enzymes: implications for drug design and polypeptide processing.

Fairlie DP, Tyndall JD, Reid RC, Wong AK, Abbenante G, Scanlon MJ, March DR, Bergman DA, Chai CL, Burkett BA. Fairlie DP, et al. J Med Chem. 2000 Apr 6;43(7):1271-81. doi: 10.1021/jm990315t. J Med Chem. 2000. PMID: 10753465

10

Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells.

Qiu L, Burgess A, Fairlie DP, Leonard H, Parsons PG, Gabrielli BG. Qiu L, et al. Among authors: fairlie dp. Mol Biol Cell. 2000 Jun;11(6):2069-83. doi: 10.1091/mbc.11.6.2069. Mol Biol Cell. 2000. PMID: 10848630 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

403 results

Search Page

Filters